Riskpilot← Back to searchSign inGet full accessSchariot Oral Hälsa AB
ABActiveOrg 5565873741Samuel Bagges Väg 36Dental practice care activities · NACE 8623Est. 20005 employees
Revenue 2024
SEK 8,5M
+2% vs 2023
EBITDA margin
54.2%
+187% vs 2023
Equity ratio
74.8%
Financial strength
Net profit 2024
SEK 3,6M
+185% vs 2023
| Revenue | SEK 8,5M | +2% |
| EBITDA | SEK 4,6M | +187% |
| Net profit | SEK 3,6M | +185% |
| Total assets | SEK 9,4M | +41% |
| Equity | SEK 7M | +44% |
| Employees | 5 | — |
Legal name
Schariot Oral Hälsa AB
Org number
5565873741
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
27 mars 2000
Share capital
SEK 100 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av Schariot, Benjamin Schariot, Stina Maria
Company purpose
Bolaget skall bedriva tandläkarpraktik och handel med värdepapper och därmed förenlig verksamhet.
Address
Samuel Bagges Väg 36
Phone
+4630213666
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 847 | 5 795 | 7 251 | 8 331 | 8 479 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 269 | 1 306 | 1 682 | 1 603 | 4 598 |
| Depreciation & amort. | −244 | −266 | −166 | −111 | −116 |
| EBIT | 25 | 1 040 | 1 516 | 1 492 | 4 482 |
| Net financials | −28 | — | 1 | 80 | 15 |
| Profit before tax | 466 | 1 431 | 1 517 | 1 572 | 4 497 |
| Tax | −108 | −303 | −320 | −321 | −934 |
| Net profit | 358 | 1 128 | 1 197 | 1 251 | 3 563 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 267 | 6 402 | 6 622 | 6 687 | 9 421 |
| Equity | 4 807 | 4 534 | 4 931 | 4 883 | 7 046 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 070 | 1 868 | 1 691 | 1 804 | 2 375 |
| Total debt | 1 070 | 1 868 | 1 691 | 1 804 | 2 375 |
EBITDA margin
54.2%
This company
15.8%
Market median
+243% vs market
20202024
Equity ratio
74.8%
This company
38.2%
Market median
+96% vs market
20202024
Return on equity
50.6%
This company
18.4%
Market median
+175% vs market
20202024
Net profit margin
42.0%
This company
8.1%
Market median
+419% vs market
20202024
Asset turnover
0.90×
This company
1.12×
Market median
+20% vs market
20202024
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CJ | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Schariot Oral Hälsa AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Joacim Gustavsson | Audit | 0 companies |
| Benjamin Schariot | Board of Directors | 0 companies |
| Stina Maria Schariot | Deputy Board Member | 0 companies |